Article

Multi-Analyte Liquid Biopsies for Treatment Guidance in Advanced Refractory Cancers: Findings of the LIQUID IMPACT Trial

2020-08-19

Abstract excerpt

<title>Abstract</title> <p>Background LIQUID IMPACT (CTRI/2019/02/017548) is a single arm, open label, phase II/III study to evaluate the feasibility of providing therapeutic guidance in cancers based on non-invasive interrogation of circulating tumor analytes in peripheral blood (Encyclopedic Liquid Biopsy: eLB). The study enrolled patients with solid organ cancers where the disease had progressed following sys...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2e4c74a8-df63-5c77-bc6f-518f8fa9e939
DOI: 10.21203/rs.3.rs-56813/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-Analyte Liquid Biopsies for Treatment Guidance in Advanced Refractory Cancers: Findings of the LIQUID IMPACT TrialDOI 10.21203/rs.3.rs-56813/v1Read

Multi-Analyte Liquid Biopsies for Molecular Pathway Guided Personalized Treatment Selection in Advanced Refractory Cancers: A Clinical Utility Pilot StudySemantic proximity Read

Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapiesSemantic proximity Read

Liquid biopsy enters the clinic - implementation issues and future challenges.Semantic proximity Read

Liquid Biopsy in the Clinical Management of CancersSemantic proximity Read

The potential of liquid biopsies for the early detection of cancerSemantic proximity Read

The significance of using liquid biopsy to improve treatment outcomes for metastatic patientsSemantic proximity Read

The implementation of liquid biopsies in routine care of patients with advanced solid cancer (LIQPLAT): a study protocol for a single arm trialSemantic proximity Read

Update on the types and usage of liquid biopsies in the clinical setting: a systematic review.Semantic proximity Read

Genomic profiling and expanded use of targeted anticancer drugs in solid cancers with exhausted evidence-based treatment options: the PRECODE study protocolSemantic proximity Read

Liquid biopsy: current technology and clinical applicationsSemantic proximity Read

AI enabled exome and transcriptome liquid biopsy platform spanning the continuum of care in oncologySemantic proximity Read

Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).Semantic proximity Read